Simplifying residual DNA analysis in viral vector production: focus on E1A
Cell & Gene Therapy Insights 2022; 8(7), 837–840
DOI: 10.18609/cgti.2022.129
Published: 12 August 2022
Innovator Insight
In this summury, Srinath Kashi Ranganath summarises how residual DNA analysis of the E1A fragment can be performed for therapeutic-grade AAV production.